Skip to main content
OpenTrials
Completed

NCT Number: NCT04217811

Late Neutropenia in VLBW Preterm Babies

There are rare reports regarding late neutropenua in very low birth weight preterm infants.

The investigators wish to characterize it among our population, and assess its consequenses and the postnatal menagement of the infants.

Completed

Looking for future studies?

Notify Me

Key information

Age range

Up to 30 day

Sex eligibility

All sexes

Study type

Observational

Primary location

Hillel Yaffe medical center

Hadera, 38100, Israel

About this study

There are rare reports regarding late neutropenua in very low birth weight preterm infants.

The investigators wish to characterize it among our population, and assess its consequenses and the postnatal menagement of the infants.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Preterm infant with birth weight up to 1500 gram

Exclusion criteria

  • Early neutroenia - neutrophil count < 1500 at the first week

Treatment and study plan

No intervention

Other

No intervention

Primary outcomes

  1. Length of stay

    Time frame: 2 weeks

    Number of days

Sponsors and collaborators

Lead sponsor

Hillel Yaffe Medical Center

Other Gov

Registry information

Official study title

Late Neutropenia in VLBW Preterm Babies - Characterization and Post Natal Menagement

Important dates

Study start
2020
Primary completion
2021
Study completion
2021
First posted
Jan 3, 2020
Registry last updated
Aug 18, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.